Subscribe

0

Biocon

Kiran Mazumdar Shaw, Biocon Sectors

Biocon's Official Fined for Insider Trading

The regulator's investigation showed that Singh, who held 9,550 equity shares of the company, acquired through exercise of stock options, sold 3,550 equity shares of the company from May 29, 2018 to September 28, 2018 without seeking preclearance from the compliance officer.

By SMEStreet Edit Desk
Oct 24, 2020 11:20 IST 2 Min read
Kiran Mazumdar Shaw, Biocon Sectors
Tata Capital to Acquires Stakes in Biocon Biologics for Rs 225 Cr
By SMEStreet Desk
Jul 31, 2020 06:31 IST 2 Min read
Kiran Mazumdar Shaw, Biocon News
DGCI Approved Biocon's CytoSorb for COVID-19 Treatment
By SMEStreet Desk
May 27, 2020 09:04 IST 1 Min read
Morgan Stanley Banking & Finance
Tata Consumer, IGL, Biocon Might Make it to MSCI Index: Morgan Stanley
By SMEStreet Desk
May 11, 2020 03:51 IST 2 Min read
Kiran Mazumdar Shaw, Biocon InFocus
Biocon's Kiran Mazumdar-Shaw Recognised Among World's Top Inspirational Leaders in BioPharma
By SMEStreet Edit Desk
Apr 28, 2020 04:00 IST 1 Min read
Biocon, Kiran Mazumdar Shaw, Syngene InFocus
Biocon's Syngene International Opened Centre for Advanced Protein Studies
By SMEStreet Desk
Apr 09, 2019 01:54 IST 2 Min read
Kiran Mazumdar Shaw, Biocon News
Biocon to Divest 2% Stake in Syngene to Comply with Minimum Public Shareholding
By SMEStreet Desk
May 16, 2018 06:02 IST 1 Min read
Kiran Mazumdar Shaw, Biocon News
BioCon to Start New R&D Facility and Create 1500 Jobs in Telengana
By SMEStreet Desk
Feb 24, 2018 03:55 IST 2 Min read
Biocon, Kiran Mazumdar Shaw, Syngene InFocus
Biocon’s Kiran Mazumdar Shaw and Yes Bank’s Rana Kapoor Named as the Most Respected Entrepreneurs of 2017 by Hurun
By SMEStreet Desk
Dec 18, 2017 13:40 IST 3 Min read
Kiran majumdar Shaw, Biocon InFocus
European Medical Agency to Review Biocon's Anti Cancer Biosimilar Trastuzumab
By SMEStreet Desk
Aug 26, 2016 03:40 IST 7 Min read
1 2 ... Next